Drug Discovery World
JANUARY 23, 2023
The Covid-19 pandemic demonstrated the power of the scientific community to rapidly mobilise resources and accelerate vaccines and treatments using novel technologies. We witnessed the unprecedented pace of vaccine development, fuelled by cutting-edge mRNA technology.
Drug Discovery World
JANUARY 26, 2023
Research into HIV blossomed throughout 2022, with ViiV Healthcare’s combination therapy for HIV-1 gaining approval in Japan; and research moving forward towards a one-time treatment for HIV as well as a vaccine. In terms of activity, a number of large-scale acquisitions took place, with Pfizer’s purchase of Biohaven for $11.6
Expert insights. Personalized for you.
59 
Let's personalize your content